{"id":"https://openalex.org/W2899323717","doi":"https://doi.org/10.1093/jac/dky415","title":"Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans","display_name":"Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans","publication_year":2018,"publication_date":"2018-10-19","ids":{"openalex":"https://openalex.org/W2899323717","doi":"https://doi.org/10.1093/jac/dky415","mag":"2899323717","pmid":"https://pubmed.ncbi.nlm.nih.gov/30376079"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dky415","doi":"https://doi.org/10.1093/jac/dky415","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dky415","pdf_url":"https://academic.oup.com/jac/article-pdf/74/2/442/27524662/dky415.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jac/article-pdf/74/2/442/27524662/dky415.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033386739","display_name":"Kashyap Patel","orcid":"https://orcid.org/0000-0002-8790-906X","observed_orcids":["https://orcid.org/0000-0002-8790-906X"]},"institutions":[{"id":"https://openalex.org/I4210119960","display_name":"Certara (United States)","ror":"https://ror.org/02kxjqp24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119960"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Kashyap Patel","raw_affiliation_strings":["Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia","d3 Medicine, A Certara Company, Parsippany, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"d3 Medicine, A Certara Company, Parsippany, NJ, USA","institution_ids":["https://openalex.org/I4210119960"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042046351","display_name":"Carl M. J. Kirkpatrick","orcid":"https://orcid.org/0000-0002-5715-1534","observed_orcids":["https://orcid.org/0000-0002-5715-1534"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Carl M Kirkpatrick","raw_affiliation_strings":["Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021253355","display_name":"Keith A. Nieforth","orcid":"https://orcid.org/0009-0005-2170-4853","observed_orcids":["https://orcid.org/0009-0005-2170-4853"]},"institutions":[{"id":"https://openalex.org/I4210119960","display_name":"Certara (United States)","ror":"https://ror.org/02kxjqp24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119960"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith A Nieforth","raw_affiliation_strings":["d3 Medicine, A Certara Company, Parsippany, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d3 Medicine, A Certara Company, Parsippany, NJ, USA","institution_ids":["https://openalex.org/I4210119960"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061249871","display_name":"Sushmita M. Chanda","orcid":"https://orcid.org/0000-0003-2290-5428","observed_orcids":["https://orcid.org/0000-0003-2290-5428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sushmita Chanda","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100704869","display_name":"Qingling Zhang","orcid":"https://orcid.org/0000-0002-5287-264X","observed_orcids":["https://orcid.org/0000-0002-5287-264X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qingling Zhang","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103255024","display_name":"Matthew W. McClure","orcid":"https://orcid.org/0000-0003-1162-3898","observed_orcids":["https://orcid.org/0000-0003-1162-3898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew McClure","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071792303","display_name":"John Fry","orcid":"https://orcid.org/0000-0002-7647-2456","observed_orcids":["https://orcid.org/0000-0002-7647-2456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Fry","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084329583","display_name":"Julian A. Symons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julian A Symons","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002911762","display_name":"Lawrence Mitchell Blatt","orcid":"https://orcid.org/0000-0002-6442-9207","observed_orcids":["https://orcid.org/0000-0002-6442-9207"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence M Blatt","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054686732","display_name":"Leo N. Beigelman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leo Beigelman","raw_affiliation_strings":["Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036771694","display_name":"John P. DeVincenzo","orcid":"https://orcid.org/0000-0003-2655-344X","observed_orcids":["https://orcid.org/0000-0003-2655-344X"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]},{"id":"https://openalex.org/I4210156806","display_name":"Le Bonheur Children's Hospital","ror":"https://ror.org/056wg8a82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156806"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P DeVincenzo","raw_affiliation_strings":["Departments of Pediatrics and Microbiology, Immunology and Biochemistry, University of Tennessee Center for Health Sciences, and Children\u2019s Foundation Research Institute at LeBonheur Children\u2019s Hospital, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pediatrics and Microbiology, Immunology and Biochemistry, University of Tennessee Center for Health Sciences, and Children\u2019s Foundation Research Institute at LeBonheur Children\u2019s Hospital, Memphis, TN, USA","institution_ids":["https://openalex.org/I160606119","https://openalex.org/I4210156806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017386423","display_name":"Dymphy R. H. Huntjens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Dymphy R Huntjens","raw_affiliation_strings":["Janssen R&D, Janssen Pharmaceutica NV, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, Janssen Pharmaceutica NV, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012385241","display_name":"Patrick F. Smith","orcid":"https://orcid.org/0000-0002-6003-0805","observed_orcids":["https://orcid.org/0000-0002-6003-0805"]},"institutions":[{"id":"https://openalex.org/I4210119960","display_name":"Certara (United States)","ror":"https://ror.org/02kxjqp24","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119960"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Patrick F Smith","raw_affiliation_strings":["d3 Medicine, A Certara Company, Parsippany, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d3 Medicine, A Certara Company, Parsippany, NJ, USA","institution_ids":["https://openalex.org/I4210119960"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5012385241"],"corresponding_institution_ids":["https://openalex.org/I4210119960"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":2.1436,"has_fulltext":true,"cited_by_count":40,"citation_normalized_percentile":{"value":0.87283385,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"74","issue":"2","first_page":"442","last_page":"452"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/respiratory-syncytial-virus-a","display_name":"respiratory syncytial virus A","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8889999985694885},{"id":"https://openalex.org/keywords/viral-dynamics","display_name":"viral dynamics","score":0.6949999928474426},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.41100001335144043},{"id":"https://openalex.org/keywords/mathematical-modeling","display_name":"mathematical modeling","score":0.3580000102519989},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6544042229652405},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6352297067642212},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.6138647198677063},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5752359628677368},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5690889954566956},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.5498875379562378},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5419645309448242},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4911753833293915},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.4453495442867279},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.4350530505180359},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4283655881881714},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42255303263664246},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4099615812301636},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39801496267318726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3117640018463135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18407955765724182},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0867997407913208},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009305","descriptor_name":"Nasopharynx","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018113","descriptor_name":"Respiratory Syncytial Virus, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018113","descriptor_name":"Respiratory Syncytial Virus, Human","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018357","descriptor_name":"Respiratory Syncytial Virus Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/dky415","doi":"https://doi.org/10.1093/jac/dky415","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dky415","pdf_url":"https://academic.oup.com/jac/article-pdf/74/2/442/27524662/dky415.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:30376079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30376079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/jac/dky415","doi":"https://doi.org/10.1093/jac/dky415","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dky415","pdf_url":"https://academic.oup.com/jac/article-pdf/74/2/442/27524662/dky415.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2899323717.pdf","grobid_xml":"https://content.openalex.org/works/W2899323717.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W105671925","https://openalex.org/W152943885","https://openalex.org/W751303237","https://openalex.org/W1582033271","https://openalex.org/W1752888260","https://openalex.org/W1857608076","https://openalex.org/W1885197335","https://openalex.org/W1965987183","https://openalex.org/W1983573719","https://openalex.org/W1986058047","https://openalex.org/W1989148061","https://openalex.org/W1999521622","https://openalex.org/W2007583880","https://openalex.org/W2023327445","https://openalex.org/W2024700382","https://openalex.org/W2042553471","https://openalex.org/W2044486890","https://openalex.org/W2074207170","https://openalex.org/W2076472674","https://openalex.org/W2077290707","https://openalex.org/W2080843536","https://openalex.org/W2088996598","https://openalex.org/W2091277908","https://openalex.org/W2105926948","https://openalex.org/W2109977701","https://openalex.org/W2115678706","https://openalex.org/W2120949068","https://openalex.org/W2129415799","https://openalex.org/W2130719514","https://openalex.org/W2139819552","https://openalex.org/W2139841187","https://openalex.org/W2145445974","https://openalex.org/W2161135604","https://openalex.org/W2199740160","https://openalex.org/W2334783812","https://openalex.org/W2539389402","https://openalex.org/W2552693719","https://openalex.org/W2586221134","https://openalex.org/W2621600493","https://openalex.org/W2727509207","https://openalex.org/W4254903140"],"related_works":["https://openalex.org/W4384819715","https://openalex.org/W2253669965","https://openalex.org/W2621600493","https://openalex.org/W1724204672","https://openalex.org/W2334783812","https://openalex.org/W2117117816","https://openalex.org/W2547905354","https://openalex.org/W7131247429","https://openalex.org/W1899571094","https://openalex.org/W2990834206"],"abstract_inverted_index":{"Background:":[0],"Respiratory":[1],"syncytial":[2],"virus":[3],"(RSV)":[4],"causes":[5],"high":[6],"morbidity,":[7],"with":[8,182],"mortality":[9],"rates":[10],"approaching":[11],"or":[12,26],"exceeding":[13],"that":[14,136,201],"of":[15,94,104,145,227],"influenza":[16],"in":[17,34,65,211,229,242],"adult":[18,212,231,243],"and":[19,47,87,91,102,106,120,147,151,170,195,205,213,223,244],"infant":[20],"patient":[21],"populations,":[22],"respectively.":[23,155],"Lumicitabine":[24],"(ALS-008176":[25],"JNJ-64041575)":[27],"is":[28,236],"an":[29,61,73,230],"oral":[30],"nucleoside":[31,52],"analogue":[32],"prodrug":[33,42],"clinical":[35],"development":[36],"to":[37,44,49,68,161,165,197,238],"treat":[38],"RSV":[39,75,85,128,172,221],"infections.":[40],"This":[41,234],"converts":[43],"plasma-circulating":[45],"ALS-8112,":[46],"then":[48],"the":[50,88,114,224],"5'-active":[51],"triphosphate":[53],"(NTP)":[54],"form":[55],"within":[56],"host":[57],"cells.":[58],"We":[59],"conducted":[60],"RSV-A":[62],"challenge":[63,232],"study":[64,115],"healthy":[66],"adults":[67],"evaluate":[69],"lumicitabine's":[70],"activity":[71],"during":[72,96],"active":[74,166],"infection.":[76],"Objectives:":[77],"To":[78],"develop":[79],"a":[80,133,138],"semi-mechanistic":[81,218],"mathematical":[82],"model":[83,135,158,219,235],"describing":[84],"kinetics,":[86],"pharmacokinetics":[89],"(PK)":[90],"pharmacodynamics":[92],"(PD)":[93],"lumicitabine":[95,176,228],"treatment.":[97],"Methods:":[98],"Nasopharyngeal":[99],"viral":[100,118,184],"load":[101],"concentrations":[103],"ALS-8112":[105,146,163],"ALS-8144":[107,148],"(uridine":[108],"metabolite)":[109],"were":[110,123,149],"measured":[111],"frequently":[112],"over":[113],"duration.":[116],"Population":[117],"kinetic":[119],"PK/PD":[121],"models":[122],"developed":[124],"using":[125,132],"NONMEM.":[126],"The":[127,142,217],"life-cycle":[129],"was":[130,159],"described":[131],"target-cell-limited":[134],"included":[137],"physiological":[139],"delay.":[140],"Results:":[141],"estimated":[143],"clearances":[144],"54.2":[150],"115":[152],"L/h/70":[153],"kg,":[154],"A":[156],"semi-physiological":[157],"linked":[160],"predict":[162],"conversion":[164],"intracellular":[167],"NTP.":[168],"Extensive":[169],"rapid":[171,202],"reduction":[173],"occurred":[174],"after":[175,189],"treatment":[177],"(EC50":[178],"=":[179],"1.79":[180],"\u03bcM),":[181],">99%":[183],"inhibition":[185],"at":[186],"2":[187],"h":[188],"loading":[190],"dose.":[191],"Simulated":[192],"NTP":[193],"exposures":[194],"time":[196],"EC50":[198],"attainment":[199],"suggested":[200],"therapeutic":[203],"effects":[204],"reduced":[206],"dosing":[207],"frequency":[208],"are":[209],"achievable":[210],"paediatric":[214,245],"patients.":[215,246],"Conclusions:":[216],"characterizes":[220],"kinetics":[222],"antiviral":[225],"effectiveness":[226],"population.":[233],"applicable":[237],"guide":[239],"dose":[240],"selection":[241]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-11-09T00:00:00"}